MAM
SGMO

Martingale Asset Management’s SANGAMO THERAPEUTICS INC SGMO Stock Holding History

Martingale Asset Management’s Portfolio SGMO Stock Details SGMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-19,153
Closed -$144K – 868
2021
Q4 		$144K Hold
19,153
– – ﹤0.01% 806
2021
Q3 		$173K Buy
19,153
+1,200
+7% +$11.9K ﹤0.01% 829
2021
Q2 		$215K Buy
+17,953
New +$203K ﹤0.01% 790
2020
Q2 		– Sell
-19,050
Closed -$122K – 1066
2020
Q1 		$122K Sell
19,050
-31,800
-63% -$236K ﹤0.01% 942
2019
Q4 		$426K Buy
50,850
+1,700
+3% +$15.6K ﹤0.01% 888
2019
Q3 		$445K Buy
49,150
+11,001
+29% +$123K ﹤0.01% 894
2019
Q2 		$411K Buy
+38,149
New +$406K ﹤0.01% 915

Other funds holding SGMO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Martingale Asset Management's SGMO Position: Q1 2022 in Review

Martingale Asset Management sold out of SANGAMO THERAPEUTICS INC (SGMO) in Q1 2022, closing a stake of 19,153 shares — an estimated $144K sold.

Martingale Asset Management first reported a position in SGMO in Q2 2019 and held it in 7 quarters. The position peaked at $445K in Q3 2019. 195 funds tracked by Wall St. Rank hold SGMO as of Q1 2022.

  • Martingale Asset Management reported no remaining SANGAMO THERAPEUTICS INC position as of Q1 2022 after selling out during the quarter.
  • Martingale Asset Management sold 19,153 SANGAMO THERAPEUTICS INC shares in Q1 2022, an estimated $144K.
  • Martingale Asset Management first reported a position in SANGAMO THERAPEUTICS INC in Q2 2019 and held it in 7 quarters.
  • Martingale Asset Management's SANGAMO THERAPEUTICS INC position peaked at $445K in Q3 2019.
  • 195 funds tracked by Wall St. Rank held SANGAMO THERAPEUTICS INC as of Q1 2022.

Based on Martingale Asset Management's 13F filing for Q1 2022, filed 12 May 2022.